DR info

Clinical trials : 76 / Drugs : 98 - (DrugBank : 31) / Drug target genes : 44 - Drug target pathways : 65

Spinocerebellar degeneration and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
18	Spinocerebellar degeneration	-
13	Multiple sclerosis/Neuromyelitis optica	39.642
6	Parkinson disease	36.501
206	Fragile X syndrome	33.600
97	Ulcerative colitis	30.613
2	Amyotrophic lateral sclerosis	30.307
156	Rett syndrome	27.971
8	Huntington disease	27.657
17	Multiple system atrophy	27.605
3	Spinal muscular atrophy	26.997
5	Progressive supranuclear palsy	24.615
140	Dorabe syndrome	20.969
144	Lennox-Gastaut syndrome	20.847
205	Fragile X syndrome related disease	20.651
193	Prader-Willi syndrome	19.336
96	Crohn disease	19.185
46	Malignant rheumatoid arthritis	19.023
21	Mitochondrial disease	17.258
152	PCDH19 related syndrome	16.000
70	Spinal stenosis	15.674
84	Sarcoidosis	14.909
145	West syndrome	14.400
203	22q11.2 deletion syndrome	14.000
296	Biliary atresia	13.827
201	Angelman syndrome	13.188
98	Eosinophilic gastrointestinal disease	13.109
22	Moyamoya disease	12.844
158	Tuberous sclerosis	12.754
34	Neurofibromatosis	12.503
272	Fibrodysplasia ossificans progressiva	12.034
298	Hereditary pancreatitis	11.958
155	Acquired aphasia with convulsive disorder	11.378
36	Epidermolysis bullosa	11.167
231	Alpha-1-antitrypsin deficiency	10.403
75	Cushing disease	10.335
85	Idiopathic interstitial pneumonia	3.612
113	Muscular dystrophy	3.540
49	Systemic lupus erythematosus	3.491
78	Hypopituitarism	2.618
127	Frontotemporal lobar degeneration	2.123
120	Hereditary dystonia	2.000
215	Tetralogy of Fallot	1.790
4	Primary lateral sclerosis	1.725
65	Primary immunodeficiency	1.549
299	Cystic fibrosis	1.520
171	Wilson disease	1.363
179	Williams syndrome	1.133
235	Hypoparathyroidism	1.044
220	Rapidly progressive glomerulonephritis	1.000
30	Distal myopathy	1.000